Loading...

Stock Snapshot

{{stockQuote.companyFullName}}
{{stockQuote.quoteInfo}}
{{stockQuote.valueFormatted}}
{{getFormattedValue(stockQuote.changesValueFormatted)}} ({{getFormattedValue(stockQuote.changesPercentFormatted)}}%)
{{getFormattedDateTime(stockQuote.delayDate)}}
{{stockQuote.onlyDateFormatted}} (At Close)
Previous Close
{{todayDetailedInformation.previousClose}}
Volume
{{todayDetailedInformation.volume}}
Today’s Open
{{todayDetailedInformation.todaysOpen}}
Average Volume (10 days)
{{detailQuote.averageVolume}}
Day's Range
{{todayDetailedInformation.todaysLow}} - {{todayDetailedInformation.todaysHigh}}
Market Cap
{{detailQuote.marketCap}}
52 Week Range
{{detailQuote.weekLow}} -{{detailQuote.weekHigh}}
Total Shares Outstanding
{{detailQuote.totalSharesOutstanding}}
More Info

Latest Company Reports

Latest Press Releases

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

{{getFormattedDate('2024-01-30T08:05:00.0000000')}}

Company Profile

DSS focuses on operating business segments in blockchain security, consumer, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets.

The DSS business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs.

Sector

Industry